A community for Denmark's biotechnology leaders.

The small country of Denmark has proved itself to be a powerhouse among European biotech communities. The BioDanmarks Hotbed is rapidly catching up to the leaders in the biopharmaceutical market, ranking fourth in Phase III public company pipelines according to Ernest & Young. Denmark is also part of the Medicon Valley, which is becoming a major center for biotechnology activity in Europe.

Join the World Discussion Forum


Hotbed News
Zealand Pharma  (ZEAL.CO), Boehringer Ingelheim Corporation Strike $402 Million Peptide Pact Tuesday, July 29, 2014
Veloxis Pharmaceuticals A/S (VELO) Release: Envarsus® Receives European Marketing Authorization For Treatment Of Both Kidney And Liver Transplant Patients Monday, July 28, 2014
BioAlliance Pharma: Approval Of Onxeo’s Admission To Secondary Listing And Trading On NASDAQ OMX Copenhagen Thursday, July 24, 2014
Bavarian Nordic (BAVA.CO) Announces First Patient Treated In A Phase 1 Study Of MVA-BN® Brachyury In Advanced Cancer Thursday, July 24, 2014
Commentary: BioSpace (DHX) Readers Sound Off On Big Pharma Takeovers Thursday, July 24, 2014
Using A Nicotine Patch During Pregnancy Tied To Higher ADHD Risk, Aarhus University Study Wednesday, July 23, 2014
Genmab A/S (GEN.CO) Announces Phase 3 Study Of Daratumumab In Front Line Multiple Myeloma Monday, July 21, 2014
New Maps Reveal "Real" Ethnic Make-Up Of The U.S. Friday, July 18, 2014
Blood Of Oldest Woman In The World Reveals Secrets Of Longevity, VU University Medical Center Study Wednesday, July 16, 2014
BioTie Therapies Corp. Selects Bracket's CDR System™ For Phase 2 Trial Of Treatment Of Parkinson's Disease Wednesday, July 16, 2014
12345678910